Antisense and RNAi Therapeutics Market Report

Global and China Antisense and RNAi Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 19, 2022
  • PAGES：163
  • REPORT CODE：GMM1390401
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology.

    The potential commercialization of a few candidates under research and development will help the antisense and RNAi therapeutics market to pick up pace in North America in the near future.

    This report elaborates on the current development of the Antisense and RNAi Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Tekmira Pharmaceuticals

    • Arbutus Biopharma

    • Alnylam Pharmaceuticals

    • Antisense Therapeutics

    • Silence Therapeutics

    • Isis Pharmaceuticals

    • Sirnaomics

    • Santaris

    • Roche

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • RNA Interference

    • Antisense RNA

    Application:

    • Hospital

    • Clinic

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Antisense and RNAi Therapeutics Industry Overview

      • 1.1.1 Antisense and RNAi Therapeutics Market Scope and Market Segments

      • 1.1.2 Antisense and RNAi Therapeutics Industry Characteristics

      • 1.1.3 Global and China Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Antisense and RNAi Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Antisense and RNAi Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 RNA Interference

      • 1.2.2 Antisense RNA

    • 1.3 Global Antisense and RNAi Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinic

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Antisense and RNAi Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Antisense and RNAi Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Antisense and RNAi Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Antisense and RNAi Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Antisense and RNAi Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Antisense and RNAi Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Antisense and RNAi Therapeutics Industry PEST Analysis

    • 2.3 Antisense and RNAi Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Antisense and RNAi Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Antisense and RNAi Therapeutics Industry

    Chapter 3 Global and China Antisense and RNAi Therapeutics Market, by Manufacturer

    • 3.1 Global and China Antisense and RNAi Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Antisense and RNAi Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Antisense and RNAi Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Antisense and RNAi Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Antisense and RNAi Therapeutics Market Top 3 Players

    Chapter 4 Global and China Antisense and RNAi Therapeutics Market, by Type (2017-2028)

    • 4.1 Antisense and RNAi Therapeutics Market Trend, by Type

    • 4.2 Global Antisense and RNAi Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Antisense and RNAi Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Antisense and RNAi Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Antisense and RNAi Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Antisense and RNAi Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Antisense and RNAi Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Antisense and RNAi Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Antisense and RNAi Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Antisense and RNAi Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Antisense and RNAi Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Antisense and RNAi Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Antisense and RNAi Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Antisense and RNAi Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Antisense and RNAi Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Antisense and RNAi Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Antisense and RNAi Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Antisense and RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Antisense and RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Antisense and RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Antisense and RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Antisense and RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Antisense and RNAi Therapeutics Market Analysis

    • 7.1 North America Antisense and RNAi Therapeutics Market, by Type

    • 7.2 North America Antisense and RNAi Therapeutics Market, by Application

    • 7.3 North America Antisense and RNAi Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Antisense and RNAi Therapeutics Market Analysis

    • 8.1 Europe Antisense and RNAi Therapeutics Market, by Type

    • 8.2 Europe Antisense and RNAi Therapeutics Market, by Application

    • 8.3 Europe Antisense and RNAi Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Antisense and RNAi Therapeutics Market Analysis

    • 9.1 APAC Antisense and RNAi Therapeutics Market, by Type

    • 9.2 APAC Antisense and RNAi Therapeutics Market, by Application

    • 9.3 APAC Antisense and RNAi Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Antisense and RNAi Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Antisense and RNAi Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Antisense and RNAi Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Antisense and RNAi Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Antisense and RNAi Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Antisense and RNAi Therapeutics Company Profiles

      • 11.1 Tekmira Pharmaceuticals

        • 11.1.1 Tekmira Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Arbutus Biopharma

        • 11.2.1 Arbutus Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Arbutus Biopharma Antisense and RNAi Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Alnylam Pharmaceuticals

        • 11.3.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Antisense Therapeutics

        • 11.4.1 Antisense Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Antisense Therapeutics Antisense and RNAi Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Silence Therapeutics

        • 11.5.1 Silence Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Silence Therapeutics Antisense and RNAi Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Isis Pharmaceuticals

        • 11.6.1 Isis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Isis Pharmaceuticals Antisense and RNAi Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Sirnaomics

        • 11.7.1 Sirnaomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Sirnaomics Antisense and RNAi Therapeutics Product Profiles, Application and Specification

        • 11.7.3 Sirnaomics Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Santaris

        • 11.8.1 Santaris Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Santaris Antisense and RNAi Therapeutics Product Profiles, Application and Specification

        • 11.8.3 Santaris Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Roche

        • 11.9.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Roche Antisense and RNAi Therapeutics Product Profiles, Application and Specification

        • 11.9.3 Roche Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Antisense and RNAi Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Antisense and RNAi Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Antisense and RNAi Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Antisense and RNAi Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Antisense and RNAi Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Antisense and RNAi Therapeutics Market Size and Growth Rate of RNA Interference (2017-2028)

    • Figure Global Antisense and RNAi Therapeutics Market Size and Growth Rate of Antisense RNA (2017-2028)

    • Figure Global Antisense and RNAi Therapeutics Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Antisense and RNAi Therapeutics Market Size and Growth Rate of Clinic (2017-2028)

    • Figure North America Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Antisense and RNAi Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Antisense and RNAi Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Antisense and RNAi Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Antisense and RNAi Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Antisense and RNAi Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Antisense and RNAi Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Antisense and RNAi Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Antisense and RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Antisense and RNAi Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Antisense and RNAi Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Antisense and RNAi Therapeutics Price Trend, by Type (2017-2028)

    • Table China Antisense and RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Antisense and RNAi Therapeutics Sales Value, by Type (2017-2028)

    • Table China Antisense and RNAi Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Antisense and RNAi Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Antisense and RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Antisense and RNAi Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Antisense and RNAi Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Antisense and RNAi Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Antisense and RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Antisense and RNAi Therapeutics Sales Value, by Application (2017-2028)

    • Table China Antisense and RNAi Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Antisense and RNAi Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Antisense and RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Antisense and RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Antisense and RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Antisense and RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Antisense and RNAi Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Antisense and RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Antisense and RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Antisense and RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Antisense and RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Antisense and RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Antisense and RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Antisense and RNAi Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Antisense and RNAi Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Antisense and RNAi Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Antisense and RNAi Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Antisense and RNAi Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Antisense and RNAi Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Tekmira Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tekmira Pharmaceuticals Product Profiles, Application and Specification

    • Table Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Arbutus Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arbutus Biopharma Product Profiles, Application and Specification

    • Table Arbutus Biopharma Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alnylam Pharmaceuticals Product Profiles, Application and Specification

    • Table Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Antisense Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Antisense Therapeutics Product Profiles, Application and Specification

    • Table Antisense Therapeutics Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Silence Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Silence Therapeutics Product Profiles, Application and Specification

    • Table Silence Therapeutics Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Isis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Isis Pharmaceuticals Product Profiles, Application and Specification

    • Table Isis Pharmaceuticals Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sirnaomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sirnaomics Product Profiles, Application and Specification

    • Table Sirnaomics Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Santaris Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Santaris Product Profiles, Application and Specification

    • Table Santaris Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Antisense and RNAi Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US